These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 33284370)

  • 1. Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation.
    Giustozzi M; Mazzetti M; Paciaroni M; Agnelli G; Becattini C; Vedovati MC
    Clin Drug Investig; 2021 Jan; 41(1):43-51. PubMed ID: 33284370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
    Giustozzi M; Vedovati MC; Verso M; Scrucca L; Conti S; Verdecchia P; Bogliari G; Pierpaoli L; Agnelli G; Becattini C
    Int J Cardiol; 2019 Apr; 281():56-61. PubMed ID: 30712846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs.
    Wang CL; Wu VC; Chang KH; Tu HT; Kuo CF; Huang YT; Chu PH; Kuo CC; Chang SH
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):147-154. PubMed ID: 31384926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting.
    Melillo E; Rago A; Proietti R; Attena E; Carrella M; Golino P; D'Onofrio A; Nigro G; Russo V
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):564-569. PubMed ID: 32602356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
    Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
    J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and Safety of Direct Oral Anticoagulants in the Secondary Stroke Prevention of Elderly Patients: Ljubljana Registry of Secondary Stroke Prevention.
    Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
    Clin Drug Investig; 2020 Nov; 40(11):1053-1061. PubMed ID: 32886321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
    Vedovati MC; Giustozzi M; Verdecchia P; Pierpaoli L; Conti S; Verso M; Di Filippo F; Marchesini E; Bogliari G; Agnelli G; Becattini C
    Int J Cardiol; 2018 Oct; 269():152-157. PubMed ID: 30077526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.
    Minematsu K; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Miyamoto S; Murakawa Y; Takeichi M; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
    Cerebrovasc Dis; 2019; 48(1-2):53-60. PubMed ID: 31578012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events.
    Acton EK; Hennessy S; Gelfand MA; Leonard CE; Bilker WB; Shu D; Willis AW; Kasner SE
    JAMA Neurol; 2024 Aug; 81(8):835-844. PubMed ID: 38976246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.
    Bakhai A; Darius H; De Caterina R; Smart A; Le Heuzey JY; Schilling RJ; Zamorano JL; Shah M; Bramlage P; Kirchhof P
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):299-305. PubMed ID: 29474715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of gender on the clinical outcomes of Asian non-valvular atrial fibrillation patients: insights from the prospective multicentre COOL-AF registry.
    Krittayaphong R; Phrommintikul A; Winijkul A; Methavigul K; Komoltri C; Kaewkumdee P; Yindeengam A;
    BMJ Open; 2021 May; 11(5):e043862. PubMed ID: 33958338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: follow-up data from the PREFER in AF European Registry].
    Renda G; Patti G; Sangiuolo R; Attena E; Malpezzi MG; De Caterina R;
    G Ital Cardiol (Rome); 2016 Nov; 17(11):922-931. PubMed ID: 27996998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
    Bundhun PK; Soogund MZ; Teeluck AR; Pursun M; Bhurtu A; Huang WQ
    BMC Cardiovasc Disord; 2017 Jan; 17(1):15. PubMed ID: 28056795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: the EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Popescu MI; Rasmussen LH; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lip GY
    Europace; 2016 May; 18(5):648-57. PubMed ID: 26826133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.